Batiraxcept

DB17522InvestigationalProtein Based Therapies

Batiraxcept: Overview.

Mechanism: Pharmacologically active on Growth arrest-specific protein 6
Curator reviewed
Also known as: Axl fc fusion protein avb-s6-500
Code names: AVB-S6-500 · RUGA-S6

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

10Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Batiraxcept, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.